Case Report: BAP1 Mutation and RAD21 Amplification as Predictive Biomarkers to PARP Inhibitor in Metastatic Intrahepatic Cholangiocarcinoma

INTRODUCTION: Intrahepatic cholangiocarcinoma (ICC) is a rare hepatobiliary cancer characterized by a poor prognosis and a limited response to conventional therapies. Currently chemotherapy is the only therapeutic option for patients with Stage IV ICC. Due to the poor response rate, there is an urge...

Descripción completa

Detalles Bibliográficos
Autores principales: Sabbatino, Francesco, Liguori, Luigi, Malapelle, Umberto, Schiavi, Francesca, Tortora, Vincenzo, Conti, Valeria, Filippelli, Amelia, Tortora, Giampaolo, Ferrone, Cristina R., Pepe, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7728995/
https://www.ncbi.nlm.nih.gov/pubmed/33330039
http://dx.doi.org/10.3389/fonc.2020.567289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7728995/
https://www.ncbi.nlm.nih.gov/pubmed/33330039
http://dx.doi.org/10.3389/fonc.2020.567289

Ejemplares similares